Skip to main content

Table 1 Demographics, clinical features, and analgesics administered to the patients in the four groups

From: Intranasal administration of butorphanol benefits old patients undergoing H-uvulopalatopharyngoplasty: a randomized trial

 

A

B

C

D

Age (y)

74 ± 3

73 ± 4

72 ± 4

72 ± 5

Weight (kg)

100 ± 11

99 ± 10

101 ± 8

101 ± 10

ASA class (I/II)

35/30

34/31

36/29

35/30

Hypertension or coronary heart disease (%)

29

31

28

31

Pulmonary disease (%)

14

15

17

15

Operative time (min)

115 ± 15

116 ± 14

119 ± 13

120 ± 12

PACU stay (min)

30 ± 6a

32 ± 4a

32 ± 5a

51 ± 9

Sufentanil (μg)

64 ± 12a

65 ± 10a

66 ± 9a

98 ± 11

Propofol (mg)

1379 ± 108

1382 ± 105

1377 ± 107

1381 ± 108

Postoperative fentanyl (g)

651 ± 65a,b,c

775 ± 76a,c

911 ± 101a

1232 ± 104

  1. aCompared with group D, P = 0.041; bcompared with group B, P = 0.049; ccompared with group C, P = 0.047.